Fresenius Medical Care Stock Price, News & Analysis (NYSE:FMS)

$51.94 0.35 (0.68 %)
(As of 12/13/2017 01:57 AM ET)
Previous Close$51.59
Today's Range$51.58 - $51.98
52-Week Range$39.46 - $51.98
Volume103,100 shs
Average Volume180,557 shs
Market Capitalization$31.72 billion
P/E Ratio23.16
Dividend Yield0.72%
Beta0.45

About Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care logoFresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryN/A
SectorHealthcare
SymbolNYSE:FMS
CUSIPN/A
Phone+49-6172-6090

Debt

Debt-to-Equity Ratio0.55%
Current Ratio1.22%
Quick Ratio0.98%

Price-To-Earnings

Trailing P/E Ratio23.16
Forward P/E Ratio21.92
P/E Growth2.32

Sales & Book Value

Annual Sales$17.91 billion
Price / Sales1.79
Cash Flow$3.30 per share
Price / Cash15.72
Book Value$18.65 per share
Price / Book2.78

Profitability

Trailing EPS$2.39
Net Income$1.24 billion
Net Margins7.04%
Return on Equity11.51%
Return on Assets5.00%

Miscellaneous

Employees109,319
Outstanding Shares615,720,000

Fresenius Medical Care (NYSE:FMS) Frequently Asked Questions

What is Fresenius Medical Care's stock symbol?

Fresenius Medical Care trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How often does Fresenius Medical Care pay dividends? What is the dividend yield for Fresenius Medical Care?

Fresenius Medical Care announced an annual dividend on Monday, April 24th. Shareholders of record on Monday, May 15th will be given a dividend of $0.5137 per share on Friday, May 26th. This represents a yield of 1.17%. The ex-dividend date of this dividend is Thursday, May 11th. View Fresenius Medical Care's Dividend History.

How were Fresenius Medical Care's earnings last quarter?

Fresenius Medical Care Corporation (NYSE:FMS) released its quarterly earnings results on Monday, August, 1st. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.49 by $0.01. The company earned $4.42 billion during the quarter, compared to analysts' expectations of $4.54 billion. Fresenius Medical Care had a return on equity of 11.51% and a net margin of 7.04%. View Fresenius Medical Care's Earnings History.

When will Fresenius Medical Care make its next earnings announcement?

Fresenius Medical Care is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Fresenius Medical Care.

Where is Fresenius Medical Care's stock going? Where will Fresenius Medical Care's stock price be in 2017?

7 Wall Street analysts have issued twelve-month target prices for Fresenius Medical Care's shares. Their predictions range from $44.00 to $44.00. On average, they anticipate Fresenius Medical Care's stock price to reach $44.00 in the next year. View Analyst Ratings for Fresenius Medical Care.

Who are some of Fresenius Medical Care's key competitors?

Who are Fresenius Medical Care's key executives?

Fresenius Medical Care's management team includes the folowing people:

  • Gerd Krick, Chairman of the Supervisory Board
  • Rice Powell, Chairman of the Management Board, Chief Executive Officer (Age 61)
  • Dieter Schenk, Vice Chairman of the Supervisory Board
  • Michael Brosnan, Chief Financial Officer, Member of the Management Board (Age 62)
  • Harry De Wit, Chief Executive Officer for Asia-Pacific, Member of the Management Board (Age 54)
  • Olaf Schermeier, Chief Executive Officer for Global Research and Development, Member of the Management Board (Age 44)
  • William Valle, Chief Executive Officer for North America, Member of the Management Board (Age 56)
  • Kent Wanzek, Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board (Age 58)
  • Dominik Wehner, Chief Executive Officer for Europe, Middle East and Africa (EMEA), Member of the Management Board (Age 48)
  • Ben J. Lipps, Honorary Chairman (Age 77)

Who owns Fresenius Medical Care stock?

Fresenius Medical Care's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Harding Loevner LP (26.61%), Cambiar Investors LLC (0.44%), Marathon Asset Management LLP (0.10%), Jarislowsky Fraser Ltd (0.05%), Wells Fargo & Company MN (0.05%) and Allianz Asset Management GmbH (0.04%). View Institutional Ownership Trends for Fresenius Medical Care.

Who sold Fresenius Medical Care stock? Who is selling Fresenius Medical Care stock?

Fresenius Medical Care's stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Winslow Evans & Crocker Inc., Marathon Asset Management LLP, BB&T Corp, JPMorgan Chase & Co., CIBC Asset Management Inc, Leavell Investment Management Inc. and First Trust Advisors LP. View Insider Buying and Selling for Fresenius Medical Care.

Who bought Fresenius Medical Care stock? Who is buying Fresenius Medical Care stock?

Fresenius Medical Care's stock was bought by a variety of institutional investors in the last quarter, including Harding Loevner LP, Allianz Asset Management GmbH, Guardian Capital LP, Envestnet Asset Management Inc., Cambiar Investors LLC, Crossmark Global Holdings Inc., Thornburg Investment Management Inc. and Wells Fargo & Company MN. View Insider Buying and Selling for Fresenius Medical Care.

How do I buy Fresenius Medical Care stock?

Shares of Fresenius Medical Care can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius Medical Care's stock price today?

One share of Fresenius Medical Care stock can currently be purchased for approximately $51.94.

How big of a company is Fresenius Medical Care?

Fresenius Medical Care has a market capitalization of $31.72 billion and generates $17.91 billion in revenue each year. The company earns $1.24 billion in net income (profit) each year or $2.39 on an earnings per share basis. Fresenius Medical Care employs 109,319 workers across the globe.

How can I contact Fresenius Medical Care?

Fresenius Medical Care's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090 or via email at [email protected]


MarketBeat Community Rating for Fresenius Medical Care (FMS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  261 (Vote Underperform)
Total Votes:  440
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fresenius Medical Care (NYSE:FMS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.692.62
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $46.00$46.00$46.00$46.00
Price Target Upside: 10.94% downside5.00% downside4.76% downside0.73% downside

Fresenius Medical Care (NYSE:FMS) Consensus Price Target History

Price Target History for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/11/2017Morgan StanleyDowngradeOverweight -> Equal WeightLowView Rating Details
11/13/2017DZ BankReiterated RatingBuyN/AView Rating Details
9/13/2017Royal Bank of CanadaReiterated RatingHold$44.00LowView Rating Details
6/28/2017Nord/LBReiterated RatingBuyLowView Rating Details
3/12/2017Sanford C. BernsteinReiterated RatingBuyLowView Rating Details
2/24/2017Societe GeneraleDowngradeBuy -> HoldN/AView Rating Details
12/14/2016J P Morgan Chase & CoReiterated RatingBuyN/AView Rating Details
10/18/2016CitigroupReiterated RatingBuyN/AView Rating Details
10/13/2016SunTrust BanksSet Price TargetBuy$48.00N/AView Rating Details
9/21/2016Goldman Sachs GroupReiterated RatingBuyN/AView Rating Details
8/9/2016Berenberg BankReiterated RatingBuyN/AView Rating Details
7/8/2016Jefferies GroupUpgradeUnderperform -> HoldN/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuyN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Fresenius Medical Care (NYSE:FMS) Earnings History and Estimates Chart

Earnings by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE FMS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018        
8/1/20176/30/2017$0.53$0.48$5.20 billion$4.47 billionViewListenView Earnings Details
5/3/2017Q2$0.44$0.53$4.69 billion$4.55 billionViewListenView Earnings Details
2/22/2017Q416$0.62$0.63$4.74 billion$4.69 billionViewListenView Earnings Details
10/27/2016Q316$0.52$0.54$4.55 billion$4.60 billionViewListenView Earnings Details
8/1/2016Q216$0.49$0.48$4.54 billion$4.42 billionViewN/AView Earnings Details
5/3/2016Q116$0.42$0.37$4.25 billion$4.21 billionViewN/AView Earnings Details
2/24/2016Q415$0.58$0.52$4.41 million$4.35 millionViewListenView Earnings Details
10/29/2015Q3$0.45$0.43$4.27 billion$4.23 billionViewListenView Earnings Details
7/30/2015Q215$0.42$0.40$4.13 billion$4.20 billionViewListenView Earnings Details
4/30/2015Q1$0.40$0.35$3.89 billion$3.96 billionViewN/AView Earnings Details
2/25/2015Q4$0.49$0.56$4.23 billion$4.32 billionViewN/AView Earnings Details
11/4/2014Q3$0.44$0.45$3.94 billion$4.11 billionViewN/AView Earnings Details
7/31/2014Q2$0.41$0.39$3.84 billionViewN/AView Earnings Details
5/6/2014Q1 2014$0.38$0.34$3.60 billion$3.56 billionViewN/AView Earnings Details
2/25/2014Q4$0.53$0.58ViewN/AView Earnings Details
11/5/2013$0.45$0.47ViewN/AView Earnings Details
7/30/2013$0.46$0.43ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Fresenius Medical Care (NYSE:FMS) Earnings Estimates

2017 EPS Consensus Estimate: $2.15
2018 EPS Consensus Estimate: $2.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.44$0.44$0.44
Q2 20171$0.54$0.54$0.54
Q3 20171$0.56$0.56$0.56
Q4 20171$0.61$0.61$0.61
Q1 20181$0.61$0.61$0.61
Q2 20181$0.64$0.64$0.64
Q3 20181$0.66$0.66$0.66
Q4 20181$0.66$0.66$0.66
Q1 20191$0.67$0.67$0.67
Q2 20191$0.69$0.69$0.69
Q3 20191$0.70$0.70$0.70
(Data provided by Zacks Investment Research)

Dividends

Fresenius Medical Care (NYSE:FMS) Dividend Information

Most Recent Dividend:5/26/2017
Annual Dividend:$0.37
Dividend Yield:0.71%
Dividend Growth:-2.10% (3 Year Average)
Payout Ratio:15.48% (Trailing 12 Months of Earnings)
15.61% (Based on This Year's Estimates)
14.45% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2017annual$0.511.17%5/11/20175/15/20175/26/2017
3/9/2016$0.305/10/20165/12/20165/23/2016
5/2/2014annual$0.531.57%5/13/20145/15/20145/27/2014
5/14/2013annual$0.491.42%5/14/20135/16/20135/28/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Fresenius Medical Care (NYSE FMS)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Fresenius Medical Care (NYSE FMS) News Headlines

Source:
DateHeadline
Morgan Stanley Lowers Fresenius Medical Care (FMS) to EqualMorgan Stanley Lowers Fresenius Medical Care (FMS) to Equal
www.americanbankingnews.com - December 11 at 10:36 AM
ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : December 7, 2017ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : December 7, 2017
finance.yahoo.com - December 7 at 5:34 PM
Fresenius Medical Care (FMS) a Buy on Solid Sales GrowthFresenius Medical Care (FMS) a Buy on Solid Sales Growth
investorplace.com - December 6 at 3:21 PM
Fresenius Medical Earns RS Rating UpgradeFresenius Medical Earns RS Rating Upgrade
finance.yahoo.com - December 5 at 5:06 PM
Robust Sales Growth Keep Fresenius Medical Care (FMS) a BuyRobust Sales Growth Keep Fresenius Medical Care (FMS) a Buy
investorplace.com - November 29 at 2:48 PM
Fresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising GoalFresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising Goal
finance.yahoo.com - November 29 at 9:49 AM
ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : November 27, 2017ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : November 27, 2017
finance.yahoo.com - November 27 at 5:48 PM
Fresenius Medical Care Achieves Improved Health Outcomes and Savings through National Medicare Demonstration ProgramFresenius Medical Care Achieves Improved Health Outcomes and Savings through National Medicare Demonstration Program
finance.yahoo.com - November 27 at 5:48 PM
Fresenius Medical Care Corporation (FMS) Given Average Recommendation of "Hold" by AnalystsFresenius Medical Care Corporation (FMS) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - November 26 at 6:14 PM
Heres Why You Should Offload Fresenius Medical Stock NowHere's Why You Should Offload Fresenius Medical Stock Now
www.zacks.com - November 22 at 7:32 PM
Fresenius Medical Care AG & Co. KGaA :FMS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 22, 2017Fresenius Medical Care AG & Co. KGaA :FMS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 22, 2017
finance.yahoo.com - November 22 at 7:32 PM
Capital Square 1031 Completes Two DST Offerings of Medical Office Buildings in North CarolinaCapital Square 1031 Completes Two DST Offerings of Medical Office Buildings in North Carolina
finance.yahoo.com - November 20 at 7:26 PM
Q3 2018 EPS Estimates for Fresenius Medical Care Corporation (FMS) Raised by AnalystQ3 2018 EPS Estimates for Fresenius Medical Care Corporation (FMS) Raised by Analyst
www.americanbankingnews.com - November 18 at 12:44 AM
ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : November 10, 2017ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : November 10, 2017
finance.yahoo.com - November 10 at 4:48 PM
Fresenius Medical Care Corporation (FMS) vs. Air Methods Corp (AIRM) Head-To-Head SurveyFresenius Medical Care Corporation (FMS) vs. Air Methods Corp (AIRM) Head-To-Head Survey
www.americanbankingnews.com - November 8 at 11:56 PM
Fresenius Medical Care Corporation to Post FY2017 Earnings of $2.30 Per Share, SunTrust Banks Forecasts (FMS)Fresenius Medical Care Corporation to Post FY2017 Earnings of $2.30 Per Share, SunTrust Banks Forecasts (FMS)
www.americanbankingnews.com - November 6 at 5:50 AM
Fresenius Medical Care Renal Therapies Group Announces Four Abstracts on Velphoro® Accepted for Presentation at the American Society of Nephrology Kidney WeekFresenius Medical Care Renal Therapies Group Announces Four Abstracts on Velphoro® Accepted for Presentation at the American Society of Nephrology Kidney Week
finance.yahoo.com - November 3 at 12:14 PM
Fresenius Medical Care Q3 Profit Rises; Reaffirms FY Outlook - Quick FactsFresenius Medical Care Q3 Profit Rises; Reaffirms FY Outlook - Quick Facts
www.nasdaq.com - November 2 at 8:02 PM
Fresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney ProfessionalsFresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney Professionals
finance.yahoo.com - November 2 at 8:02 PM
Fresenius Medical Care’s (FMS) Superior Quant Score Keeps it a BuyFresenius Medical Care’s (FMS) Superior Quant Score Keeps it a Buy
investorplace.com - November 1 at 7:55 PM
Fresenius Medical Care Corporation (FMS) Given Average Rating of "Hold" by AnalystsFresenius Medical Care Corporation (FMS) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 1 at 5:32 PM
Nxstage Medical (NXTM) Stockholders Approve Merger Agreement With Fresenius Medica (FMS)Nxstage Medical (NXTM) Stockholders Approve Merger Agreement With Fresenius Medica (FMS)
www.streetinsider.com - October 28 at 3:00 AM
Investors Should Feel Right At Home With Fresenius KabiInvestors Should Feel Right At Home With Fresenius Kabi
seekingalpha.com - October 28 at 3:00 AM
Fresenius Medical Care Corporation (FMS) to Release Earnings on ThursdayFresenius Medical Care Corporation (FMS) to Release Earnings on Thursday
www.americanbankingnews.com - October 26 at 5:00 AM
Fresenius Medical Care Corporation (FMS) Rating Lowered to Sell at Zacks Investment ResearchFresenius Medical Care Corporation (FMS) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - October 25 at 8:32 PM
Head-To-Head Review: Streamline Health Solutions (STRM) vs. Fresenius Medical Care Corporation (FMS)Head-To-Head Review: Streamline Health Solutions (STRM) vs. Fresenius Medical Care Corporation (FMS)
www.americanbankingnews.com - October 22 at 8:12 AM
Reviewing Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA)Reviewing Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA)
www.americanbankingnews.com - October 21 at 4:24 AM
Fresenius Medical Care’s (FMS) Solid Earnings Visibility Keeps it a BuyFresenius Medical Care’s (FMS) Solid Earnings Visibility Keeps it a Buy
investorplace.com - October 20 at 12:36 AM
Medical Device Security Market 2017: By Technology Type, End User, Application & RegionMedical Device Security Market 2017: By Technology Type, End User, Application & Region
www.finanznachrichten.de - October 13 at 9:20 PM
Head-To-Head Analysis: Fresenius Medical Care Corporation (FMS) versus The Joint Corp. (JYNT)Head-To-Head Analysis: Fresenius Medical Care Corporation (FMS) versus The Joint Corp. (JYNT)
www.americanbankingnews.com - October 13 at 2:20 PM
Fresenius Medical Care Corporation (FMS) Upgraded to Hold by Zacks Investment ResearchFresenius Medical Care Corporation (FMS) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - October 9 at 1:22 PM
Fresenius Medical Care Corporation (FMS) and Quest Diagnostics (DGX) Head-To-Head AnalysisFresenius Medical Care Corporation (FMS) and Quest Diagnostics (DGX) Head-To-Head Analysis
www.americanbankingnews.com - October 9 at 10:14 AM
Fresenius Medical Care Corporation (FMS) Given Consensus Rating of "Hold" by BrokeragesFresenius Medical Care Corporation (FMS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - October 7 at 6:50 PM
Top Executives from Fresenius Medical Care North America Come Together to Support Community and Chair Boston Kidney WalkTop Executives from Fresenius Medical Care North America Come Together to Support Community and Chair Boston Kidney Walk
finance.yahoo.com - October 5 at 5:54 PM
Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical CareQuest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care
seekingalpha.com - September 30 at 12:47 AM
HealthSouth Corporation (HLS) Ex-Dividend Date Scheduled for September 29, 2017 - NasdaqHealthSouth Corporation (HLS) Ex-Dividend Date Scheduled for September 29, 2017 - Nasdaq
www.nasdaq.com - September 28 at 9:59 AM
Abiomeds Latest Regulatory Progress Boosts Impella LineAbiomed's Latest Regulatory Progress Boosts Impella Line
www.zacks.com - September 27 at 6:18 PM
Lisa Estrada, Fresenius Medical Care North America, Joins Movement to Raise $1 Million for Kidney HealthLisa Estrada, Fresenius Medical Care North America, Joins Movement to Raise $1 Million for Kidney Health
finance.yahoo.com - September 21 at 6:50 PM
Quest Diagnostics (DGX) versus Fresenius Medical Care Corporation (FMS) Head-To-Head ComparisonQuest Diagnostics (DGX) versus Fresenius Medical Care Corporation (FMS) Head-To-Head Comparison
www.americanbankingnews.com - September 18 at 6:23 PM
Fresenius Medical Care Corporation to Post Q1 2019 Earnings of $0.67 Per Share, SunTrust Banks Forecasts (FMS)Fresenius Medical Care Corporation to Post Q1 2019 Earnings of $0.67 Per Share, SunTrust Banks Forecasts (FMS)
www.americanbankingnews.com - September 18 at 8:00 AM
Fresenius Medical Care North America Announces Scholarship Program for Nurses of the American Nephrology Nurses AssociationFresenius Medical Care North America Announces Scholarship Program for Nurses of the American Nephrology Nurses Association
finance.yahoo.com - September 15 at 7:16 PM
Analyzing Quest Diagnostics (DGX) and Fresenius Medical Care Corporation (FMS)Analyzing Quest Diagnostics (DGX) and Fresenius Medical Care Corporation (FMS)
www.americanbankingnews.com - September 15 at 6:29 PM
Fresenius Medical Care Corporations (FMS) "Hold" Rating Reiterated at Royal Bank Of CanadaFresenius Medical Care Corporation's (FMS) "Hold" Rating Reiterated at Royal Bank Of Canada
www.americanbankingnews.com - September 13 at 9:44 PM
Like Mother Like DaughterLike Mother Like Daughter
finance.yahoo.com - September 13 at 8:12 PM
Head to Head Comparison: Fresenius Medical Care Corporation (FMS) and its CompetitorsHead to Head Comparison: Fresenius Medical Care Corporation (FMS) and its Competitors
www.americanbankingnews.com - September 11 at 6:20 AM
Financial Survey: Fresenius Medical Care AG & Co. (FMS) and its CompetitorsFinancial Survey: Fresenius Medical Care AG & Co. (FMS) and its Competitors
www.americanbankingnews.com - September 10 at 12:24 AM
Fresenius Medical Care (FMS) Presents At 2017 Wells Fargo Healthcare Conference - SlideshowFresenius Medical Care (FMS) Presents At 2017 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 7 at 6:52 PM
Universal Health Services, Inc. (UHS) Ex-Dividend Date Scheduled for August 30 ...Universal Health Services, Inc. (UHS) Ex-Dividend Date Scheduled for August 30 ...
www.nasdaq.com - August 30 at 12:14 AM
Fresenius Medical Care Corporation (FMS) versus Mednax (MD) Financial ContrastFresenius Medical Care Corporation (FMS) versus Mednax (MD) Financial Contrast
www.americanbankingnews.com - August 25 at 8:56 AM
Fresenius Medical Care Corporation (FMS) Receives Consensus Recommendation of "Hold" from BrokeragesFresenius Medical Care Corporation (FMS) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 18 at 8:56 PM

SEC Filings

Fresenius Medical Care (NYSE:FMS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fresenius Medical Care (NYSE:FMS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fresenius Medical Care (NYSE FMS) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.